Navigation Links
Veran Medical Technologies Announces Initial Shipment of SPiN Drive® Platform to Customers
Date:1/17/2012

ST. LOUIS, Jan. 17, 2012 /PRNewswire/ -- Veran Medical Technologies announced today that the Company has started initial shipments of its SPiN Drive® electromagnetic navigation platform, an advanced solution that biopsies peripheral Solitary Pulmonary Nodules (SPNs) for the potential early diagnosis of lung cancer. 

The SPiN Drive system design may improve efficiency and enhance workflow by allowing the physician to never lose or remove navigation at the time of biopsy with the Always-On Tip Tracked™ instruments. The platform is the first in electromagnetic navigation to provide optimal facility flexibility by requiring no unique bed or room calibration.  Additionally, the ability to view airways during procedures may provide a significant advantage toward targeting SPNs.

Targets are viewed on high-resolution CT images using a patient-specific view, without any radiation being delivered to the patient, physician or staff.  In addition, the SPiN Drive technology includes bi-planar virtual fluoroscopy view used to navigate multiple planes simultaneously.  This advancement is the first of its kind in pulmonology, enabling physicians to view the location of the Always-On Tip Tracked instrument. 

"The SPiN Drive platform is ground-breaking technology in electromagnetic navigation," said Gregg Smith, vice president of sales and marketing at Veran Medical Technologies.  "The SPiN Drive system has generated tremendous market excitement since its introduction.  As expected, hospitals looking to provide the most advanced electromagnetic navigation technology for early diagnosis of lung cancer are seeking the SPiN Drive platform.  We are excited about the interest in SPiN Drive and believe we are strongly positioned for growth in 2012."  

Lung cancer is a deadly disease that mortally claims 85 percent of patients within five years. According to the recent NLST (National Lung Screen Trial) study, there is a 21 percent reduction in mortality for patients screened for lung cancer.  Many SPNs in the peripheral lung are inaccessible with today's techniques and technologies, leaving patients on "watchful waiting" protocols of repeat CT scanning causing significant patient anxiety and unproductive costs added to the U.S. Healthcare System.  Veran's SPiN Drive product acts as a GPS-like system to enable pulmonologists and surgeons to access SPNs, aid in obtaining biopsy tissue for diagnosis and end watchful waiting. 

About Veran Medical Technologies, Inc. Veran Medical Technologies is a privately held company led by a team of innovators focused on developing the next standard of care for minimally invasive delivery of interventional oncology therapies.  Veran has built several clinical products upon its ig4™ platform technology, which uses proprietary 4D registration capabilities for targeting lesions within the human body.  The company believes that by enabling minimally invasive early stage diagnosis, it can increase patient survival and lower healthcare costs significantly.  Veran Medical Technologies is headquartered in St. Louis, MO.

 

 


'/>"/>
SOURCE Veran Medical Technologies, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Veran Medical Technologies Launches New SPiN Drive™ Application for Bi-Planar Virtual Fluoroscopy View
2. Veran Medical Receives FDA Clearance to Market Electromagnetic Navigated Bronchoscopy Product: The SPiN Drive(TM) System
3. VIDA Diagnostics and Veran Medical Sign Definitive Agreement for Joint Development of Endobronchial Navigation System
4. Ventana Medical Systems, Inc. to Collaborate with Bayer on Companion Diagnostic Test for New Biological Cancer Therapy
5. The Market Outlook for Refurbished Medical Devices to 2016
6. Terumo Americas Holding Acquires Onset Medical Corporation, a Leader in Innovative Sheath Technology Designed for Multiple, Minimally Invasive Clinical Applications
7. Public Policy Staffing Study Offers Benchmark Opportunity for Bio-Pharma and Medical Device Companies
8. Arriva Medical Acquires Direct Diabetic Source
9. Aethlon Medical Establishes Sepsis & Inflammation Scientific Advisory Board
10. Simbionix Comprehensive Medical Simulators now Available in Additional Languages
11. Suneva Medical to Pursue Expanded Indications for Artefill® With Launch of Phase III Acne Scar Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/13/2017)... , January 13, 2017 On ... Jones Industrial Average, and the S&P 500 edged lower ... ended Thursday,s trading session in bearish territories. Taking into ... Services equities this morning: Myriad Genetics Inc. (NASDAQ: ... ), INC Research Holdings Inc. (NASDAQ: INCR ...
(Date:1/13/2017)... NEW YORK , Jan. 12, 2017 /PRNewswire-USNewswire/ ... type 1 diabetes (T1D) research, is pleased to ... advocacy efforts, the Centers for Medicare & Medicaid ... devices approved by the FDA for use in ... a significant step toward making them eligible for ...
(Date:1/13/2017)... YORK , Jan. 12, 2017  Rosen Law ... filing of a class action lawsuit on behalf of ... ALXN ) from February 10, 2014 through November 9, ... recover damages for Alexion investors under the federal securities ... go to http://rosenlegal.com/cases-991.html or call Phillip ...
Breaking Medicine Technology:
(Date:1/16/2017)... , ... January 16, 2017 , ... ... availability of the newly updated International Audit Protocol Consortium (IAPC) EHS audit protocol ... protocols to understand the scope of their EHS regulatory obligations and rapidly collect, ...
(Date:1/16/2017)... ... ... well-aware of the following facts at present:, Flu and cold ... effect on keeping this particularly bad strain of the flu away , In ... , These facts are well-known among the team at Woodard! About halfway ...
(Date:1/16/2017)... Hills, CA (PRWEB) , ... January 16, 2017 ... ... a manuscript in the Aesthetic Surgery Journal , the official journal of ... he conducted on lower eyelid retraction surgery. The procedure is designed to correct ...
(Date:1/16/2017)... ... 16, 2017 , ... One thing common to all types of cancer is ... as well. The money spent screening for and treating cancer in the United States ... for cancer more than in any other country that has an advanced healthcare system, ...
(Date:1/16/2017)... ... January 16, 2017 , ... Vixiar Medical, Inc. ... the medical device company, effective immediately. , “This is perfect timing for Kevin ... strong track record in medical device market development and revenue growth, particularly in ...
Breaking Medicine News(10 mins):